Oncolys BioPharma Inc. (TYO:4588)

Japan · Delayed Price · Currency is JPY

6,830.00

+340.00 (5.24%)

Oct 6, 2026, 3:30 PM JST

Oncolys BioPharma Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct '26 Oct 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	201,388	12,881	10,878	9,130	9,171	21,971
Market Cap Growth	1095.43%	18.41%	19.14%	-0.44%	-58.26%	-19.57%
Enterprise Value	199,000	11,569	9,991	7,125	5,757	20,418
Last Close Price	6830.00	518.00	567.00	527.00	528.00	1503.00

Price Ratios

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct '26 Oct 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
PS Ratio	7054.85	410.43	172.56	9.35	14.27	69.93
PB Ratio	113.72	4.68	7.38	4.23	2.55	10.97
P/TBV Ratio	113.72	4.68	7.38	4.23	2.55	10.97

EV Ratios

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct '26 Oct 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
EV/Sales Ratio	-	368.62	158.50	7.30	8.96	64.99

Financial Efficiency

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct '26 Oct 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Debt / Equity Ratio	0.19	0.12	0.21	0.18	0.14	0.26
Net Debt / Equity Ratio	-0.57	-0.76	-0.83	-0.61	-0.82	-0.77
Net Debt / EBITDA Ratio	0.50	1.24	0.63	1.08	1.95	0.92
Net Debt / FCF Ratio	-	1.03	0.91	0.77	1.69	1.05
Asset Turnover	0.01	0.01	0.03	0.28	0.18	0.09
Inventory Turnover	-	-	2.19	35.52	40.10	6.15
Quick Ratio	5.19	10.14	4.32	6.19	8.91	5.38
Current Ratio	6.62	12.28	5.17	8.11	9.76	6.13
Return on Equity (ROE)	-110.09%	-79.73%	-106.71%	-39.94%	-57.72%	-76.78%
Return on Assets (ROA)	-55.37%	-40.26%	-51.44%	-22.01%	-26.86%	-29.41%
Return on Invested Capital (ROIC)	-345.38%	-365.97%	-351.64%	-164.69%	-276.12%	-306.97%
Return on Capital Employed (ROCE)	-108.70%	-57.30%	-116.20%	-52.50%	-39.40%	-70.90%

Yields

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct '26 Oct 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Earnings Yield	-1.02%	-13.08%	-17.82%	-12.58%	-17.61%	-9.54%
FCF Yield	-0.96%	-15.71%	-12.34%	-18.82%	-19.01%	-6.68%
Buyback Yield / Dilution	-21.76%	-22.67%	-2.71%	-2.44%	-17.54%	-3.41%